A review on microplastics and nanoplastics in the environment: Their occurrence, exposure routes, toxic studies, and potential effects on human health
S Sangkham, O Faikhaw, N Munkong, P Sakunkoo… - Marine pollution …, 2022 - Elsevier
Abstract Microplastics (MPs) and nanoplastics (NPs) are emerging environmental pollutants,
having a major ecotoxicological concern to humans and many other biotas, especially …
having a major ecotoxicological concern to humans and many other biotas, especially …
[HTML][HTML] Plasticenta: First evidence of microplastics in human placenta
A Ragusa, A Svelato, C Santacroce, P Catalano… - Environment …, 2021 - Elsevier
Microplastics are particles smaller than five millimeters deriving from the degradation of
plastic objects present in the environment. Microplastics can move from the environment to …
plastic objects present in the environment. Microplastics can move from the environment to …
Detection of microplastic in human placenta and meconium in a clinical setting
T Braun, L Ehrlich, W Henrich, S Koeppel, I Lomako… - Pharmaceutics, 2021 - mdpi.com
Environmental pollution with microplastics (MPs) is a major and worldwide concern.
Involuntary exposure to MPs by ingestion or inhalation is unavoidable. The effects on human …
Involuntary exposure to MPs by ingestion or inhalation is unavoidable. The effects on human …
Microplastics in aquatic environment: Challenges and perspectives
The occurrence of microplastics in the aquatic environment has become a growing concern
globally. Microplastics pose a hazard to the ecological system, and their presence …
globally. Microplastics pose a hazard to the ecological system, and their presence …
Tracking placental development in health and disease
Pre-eclampsia and fetal growth restriction arise from disorders of placental development and
have some shared mechanistic features. Initiation is often rooted in the maldevelopment of a …
have some shared mechanistic features. Initiation is often rooted in the maldevelopment of a …
Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications: systematic review and meta-analysis
Background: Women with a history of certain pregnancy complications are at higher risk for
cardiovascular (CVD) disease. However, most clinical guidelines only recommend …
cardiovascular (CVD) disease. However, most clinical guidelines only recommend …
The role of inflammation in the pathogenesis of preeclampsia
M Michalczyk, A Celewicz, M Celewicz… - Mediators of …, 2020 - Wiley Online Library
Preeclampsia (PE) affects 5‐8% of pregnant women, and it is the major cause of perinatal
morbidity and mortality. It is defined as arterial hypertension in women after 20 weeks of …
morbidity and mortality. It is defined as arterial hypertension in women after 20 weeks of …
Preterm prelabor rupture of the membranes: a disease of the fetal membranes
Preterm prelabor rupture of the membranes (pPROM) remains a significant obstetric
problem that affects 3–4% of all pregnancies and precedes 40–50% of all preterm births …
problem that affects 3–4% of all pregnancies and precedes 40–50% of all preterm births …
Short-term costs of preeclampsia to the United States health care system
Background Preeclampsia is a leading cause of maternal morbidity and mortality and
adverse neonatal outcomes. Little is known about the extent of the health and cost burden of …
adverse neonatal outcomes. Little is known about the extent of the health and cost burden of …
Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity
Metformin is everywhere. Originally introduced in clinical practice as an antidiabetic agent,
its role as a therapeutic agent is expanding to include treatment of prediabetes mellitus …
its role as a therapeutic agent is expanding to include treatment of prediabetes mellitus …